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Abstract
Background Few studies focus on cross-cultural differences
in Chronic fatigue syndrome (CFS).
Purpose This study aimed to (1) compare fatigue severity
and impairment, somatic complaints, psychological distress,
and quality of life (QoL) in a population of Portuguese and
Dutch patients; (2) explore the differential contribution of
behavioral and cognitive determinants of fatigue severity;
and (3) investigate the relation between fatigue severity and
somatic complaints on one hand and QoL on the other in
both populations.
Method Eighty-five female patients from Portugal (Mean age0
47.54) and 167 female CFS patients from The Netherlands
(Mean age044.93) participated in the study. All participants
were surveyed for demographic and clinical characteristics,
fatigue severity, somatic symptoms, psychological distress,
(physical and psychological) QoL, physical activity, behavior
regulation patterns, and illness representations.
Results Cross-cultural differences were found in relation to
working status, duration of fatigue symptoms, psychological
distress, somatic complaints, and psychological QoL. Al-
though behavioral characteristics and illness representations
were significantly associated with fatigue severity in both
Portuguese and Dutch patients, there were important differ-
ences in the determinants of CFS. Moreover, higher levels
of fatigue and severity of other somatic complaints were
related to poor QoL.
Conclusions These findings show cross-cultural similarities
and differences in clinical characteristics and psychological
determinants of CFS that are important in view of diagnosis
and treatment.
Keywords Chronic fatigue syndrome . Fatigue severity .
Psychological determinants . Cross-cultural
Introduction
Somatic symptoms, such as fatigue, are an important reason
for doctor visits [1, 2] and it is estimated that these symptoms
remain medically unexplained in about one third of the cases
[1]. Usually, fatigue is explained by life circumstances and is
transitory, but for some, fatigue symptoms are indeed medi-
cally unexplained, can be severe and become chronic, result-
ing in functional and social impairment (e.g., inability to
work), high use of health care resources, and lower quality
of life (QoL) [2–4]. According to the Centers for Disease
Control and Prevention (CDC) fatigue is classified as chronic
fatigue syndrome (CFS) when it lasts for at least 6 months, is
not alleviated by rest, is debilitating, results in a significant
reduction of daily activities, cannot be explained by an organic
disease, and is accompanied by four or more of the following
symptoms: unrefreshing sleep, lengthy malaise after exertion
(lasting for over 24 h), impaired memory or concentration,
sore throat, tender cervical or axillary lymph nodes, muscle
pain, multi-joint pain without swelling or redness, and head-
aches of a new type or severity [5]. Comorbidity between CFS
and psychological distress (depression and anxiety) was found
in several studies, although the relationship remains unclear
[6–8]. Some prospective studies found the occurrence of
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psychiatric disorders during adulthood to be associated with
later CFS [9, 10]. Other studies suggest that the high rates of
psychological distress in CFS patients may be due to a com-
mon negative affective reaction to a chronic health problem
[6], to disability associated with fatigue [7], to difficulties in
the diagnosis of CFS [8], or as a result of the lack of legitimi-
zation of the disease by medical doctors [8] among other
explanations. Patients with CFS also experience a great num-
ber and higher severity of other somatic complaints [4, 11].
Several studies indicate that these patients are hypersensitive
to somatic sensations, which can lead to a worsening and
increase of the number of symptoms perceived [6, 12, 13].
A psychological perspective on CFS can provide a better
understanding of the cognitive and behavioral factors associ-
ated with the onset and perpetuation of unexplained fatigue [2,
6]. More specifically, patients’ illness representations and
coping strategies can contribute to the worsening and perpet-
uating of fatigue [6, 13, 14]. Patients with CFS tend to believe
that their illness has severe consequences and will last for a
long period of time (timeline), and they also expect many
associated symptoms [6, 13, 15]. A prospective study revealed
that perceived consequences, timeline, uncontrollability, and
emotional response predicted worsening and maintenance of
chronic fatigue [16]. Patients who belief that they suffer from
a severe illness, that their CFS is out of control or incurable
and will lead to adverse consequences, usually develop pas-
sive ways of coping with their illness, leading to high disabil-
ity and psychological distress [2, 13, 17]. In relation to
behavior regulation (coping), it has been suggested that CFS
patients tend to adopt a “boom-and-bust pattern” (also called
“all-or-nothing behavior”) or a limiting behavior pattern to
deal with their illness [13, 16]. All-or-nothing behavior refers
to the systematic alternation between periods of excessive
activity (when feeling good), and, as a consequence of that,
feeling extremely fatigued and having to rest for longer peri-
ods of time [13, 18]. Limiting behavior refers to the excessive
resting and inactivity, which can be associated with patient
complaints related to exercise intolerance and post-exertional
malaise. Patients’ perceptions and expectations related to
symptom exacerbation as a consequence of exercise can
explain the reduced levels of physical activity found in these
patients [6]. At the same time, lack of physical activity
and excessive resting are factors that can result in
physical deconditioning which, in turn, might perpetuate
fatigue and physical disability [19]. The importance of iden-
tifying and understanding the specific cognitive and behav-
ioral determinants of CFS is reinforced by the promising
results of CBT and graded exercise approaches in CFS
management [20, 21].
CFS is considered to be a heterogeneous clinical condition.
Patients may present with different levels of (mental and
physical) fatigue severity, psychological distress, additional
somatic symptoms, and different levels of impairment and
disability [3, 6]. For this reason, fatigue severity and related
somatic symptoms, psychological distress and QoL, may vary
between countries and cultures [22, 23]. Most studies on the
prevalence and clinical characteristics of CFS have been con-
ducted in northwestern Europe, North America, and Oceania
[23], while there are very few international studies that com-
pare patient populations from different countries [3, 22, 23].
Hickie and colleagues [22] explored CFS worldwide, using
existing data from different cultures. Results revealed a five-
factor model of symptoms (musculoskeletal pain and pro-
longed fatigue, neurocognitive difficulties, sleep disturbance,
inflammation, and mood disturbance), confirming that CFS is
indeed a universal disease. Another study on health-related
QoL conducted with US, UK, and German CFS patients
showed that these patients reported a lower QoL in all
countries [3]. In a study comparing the prevalence and recog-
nition of CFS in primary health care services between Brazil
and England [23], the prevalence of CFS appeared to be
similar in both countries, but there were differences in the
recognition of CFS as a discrete disorder leading to a lower
number of diagnosed patients in Brazil.
Likewise, cross-cultural research on the psychological
determinants of CFS, such as behavioral (e.g., physical
activity) and cognitive (e.g., illness representations) factors,
is lacking, although this type of research can contribute to
the cultural adaptation of existing CFS models and the
development of tailored treatment strategies. For this reason,
we conducted a comparative study between two economi-
cally and culturally distinct countries: Portugal (a southern
European country) and The Netherlands (a northwestern
European country), as we expected differences in clinical
characteristics and determinants of CFS. Available data
reveal differences in psychological distress and physical
activity between the two populations [24, 25].
This is an exploratory study aiming at (1) comparing fa-
tigue impairment and severity, somatic complaints, psycho-
logical distress and (physical and psychological) QoL in
Portuguese and Dutch CFS patients; (2) exploring differential
effects of behavioral (physical activity and behavior regula-
tion patterns) and cognitive factors (illness representations) on
fatigue severity in the study populations; and (3) examining
the contribution of fatigue severity and somatic complaints to
(physical and psychological) QoL in Portuguese and Dutch
CFS patients.
Method
Participants and Procedures
This cross-sectional study included participants from two
countries: Portugal and The Netherlands. In both cases,
inclusion criteria were the following: (1) meeting the CDC
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criteria for CFS [5]; (2) being at least 18 years old; (3) being
fluent in Portuguese/Dutch; (4) and having the capacity to
provide an informed consent. Exclusion criteria were similar
for both samples: presence of a concurrent somatic condi-
tion that could explain the fatigue symptoms and/or pres-
ence of a severe psychiatric disorder (according to the CDC
criteria for exclusionary medical and psychiatric condi-
tions). Table 1 presents the demographic and clinical char-
acteristics of the samples.
Participants from Portugal were recruited via various
health care institutions and from the National Chronic
Fatigue Syndrome and Fibromyalgia Patients Association.
CFS patients from the health care institutions were re-
ferred by their medical doctor based on the inclusion
and exclusion criteria for the study. Patients from the
patients association had a clinical diagnosis of unex-
plained chronic fatigue. Patients were approached by the
research team to complete the questionnaires. Participants
from The Netherlands were recruited through the National
Chronic Fatigue Syndrome Association. All Dutch patients
were medically diagnosed as having CFS. The members
of this association were invited via e-mail by the patient
association to complete the questionnaire. For both sam-
ples, informed consent was obtained, and confidentiality
of the data was guaranteed by the research team. Further-
more, the inclusion and exclusion criteria were checked
by the research team, using self-report measures (CDC
checklist of CFS symptoms; presence and name of
chronic disease; and presence and name of psychiatric
disorder).
For this study, patients from Portugal and The Nether-
lands were matched on age, gender (only female patients
were included), and diagnosis (only patients fulfilling the
CDC criteria for CFS were included).
Table 1 Descriptives and dif-
ferences in demographics and
clinical characteristics, fatigue
severity, somatic complaints,
psychological distress and QoL
for the Portuguese and the
Dutch CFS samples
Values are the mean ± SD unless
otherwise indicated
*p<0.05; **p<0.01
Portugal
(N085)
Netherlands
(N0167)
Test for
differences
Female patients, no. (%) 100 100 –
Age, years 47.54±10.75 44.93±10.98 t01.77
Educational level, no. (%) X207.02*
Primary and Lower education 27.4 16.2
Secondary education 39.3 34.7
Tertiary education 33.3 49.1
Not working, no. (%) 44.7 68.7 X2013.5**
Illness duration, months 128.81±102.41 165.71±92.22 t0−2.85**
Medical visits, no. 4.64±3.42 4.28±4.67 t00.59
CDC CFS Diagnosis, no. (%) 100 100 –
Fatigue severity 101.75±17.60 99.52±16.61 t00.99
Subjective experience of fatigue 46.73±6.88 46.34±7.96 t00.38
Subjective experience of fatigue, no. (%) X200.47
Non clinical 7.1 9.6
Clinical 92.9 90.4
Somatic complaints 15.53±4.11 14.29±4.24 t02.20*
Somatic complaints, no.(%) X203.51
Low 7.1 13.5
Medium 42.4 46.0
High 50.6 40.5
Depression 1.72±0.92 0.84±0.78 t07.61**
Depression, no. (%) X2053.09**
Non clinical 48.2 89.8
Clinical 51.8 10.2
Anxiety 1.67±0.79 0.79±0.77 t08.42**
Anxiety , no. (%) X2039.83**
Non clinical 35.3 76.0
Clinical 64.7 24.0
Physical QoL 37.22±18.40 34.83±16.91 t01.03
Psychological QoL 39.31±16.97 45.26±9.22 t0−3.61**
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Measures
Patient Characteristics
Sociodemographic characteristics include age, gender, educa-
tion, and employment status (Table 1). Clinical information
was gathered using four indicators: (1) presence of persistent
fatigue, (2) duration of fatigue symptoms (months), (3) num-
ber of doctor visits in the previous 6 months, and (4) a CDC-
based symptom checklist for CFS. The checklist includes the
eight major symptoms of CFS defined by the CDC criteria [5].
Respondents are asked to rate using a dichotomous scale (yes/
no) whether they experienced the symptoms for the last
6 months. To be diagnosed with CFS, patients need to have
a complaint of persistent unexplained fatigue for at least
6 months and have at least four of the major CFS symptoms
listed by the CDC [5].
Fatigue Severity
The Checklist of Individual Strength (CIS-20R) was used to
assess fatigue levels [26]. The CIS-20R is a 20-item self-report
questionnaire that assesses four dimensions of fatigue: subjec-
tive experience of fatigue, lack of concentration, lack of moti-
vation, and activity reduction. Items are rated on a 7-point
Likert scale ranging from “Yes, that is true” to “No, that is
not true”. A total CIS-20R score (fatigue severity), ranging
from 20 to 140, can be calculated by adding the scores from
each dimension. Higher scores indicate higher levels of fatigue
severity. For the purpose of this study, only the total fatigue
severity score and the subjective experience of fatigue dimen-
sion were used. A cut-off point of 35 for subjective experience
of fatigue [27] is used to define clinical levels of fatigue. The
CIS-20R is a well validated and reliable measure for CFS
patients [26]. Data on the Portuguese version of the CIS-20R
reveal good reliability of the dimensions subjective experience
of fatigue and total fatigue severity (α00.89 and α00.90,
respectively) [28].
Somatic Complaints
Severity of physical symptoms was measured by means of the
Patient Health Questionnaire-15 (PHQ-15) [1]. The PHQ-15
assesses the presence and severity of 15 somatic symptoms
(e.g., back pain). A higher score indicates a higher level of
somatization. Moreover, scores of 5, 10, and 15 represent cut-
off points for low, medium, and high somatic symptom sever-
ity, respectively [1].
Psychological Distress
The depression and anxiety subscales from the validated
Brief Symptom Inventory (BSI) were used to assess levels
of psychological distress [29]. Individuals rank each symp-
tom on a 5-point Likert scale (from “never” to “very frequent-
ly”). Final scores range from 0 to 4 and higher scores represent
higher levels of depression and anxiety. Cut-off points of 1.80
and 1.33 are used to define clinical levels of depression and
anxiety, respectively [30].
Quality of Life
The Short Form Health Survey-12 (SF-12 v2) [31] was used to
assess physical and psychological functioning and overall
health-related QoL. The SF-12v2 is a well validated measure
consisting of eight domains: (1) general health perception, (2)
physical functioning, (3) role limitations due to physical prob-
lems, (4) bodily pain, (5) vitality, (6) role limitations due to
emotional problems, (7) social functioning, (8) and mental
health. These eight dimensions are combined into a physical
functioning score (physical QoL) and a psychological function-
ing score (psychological QoL), ranging from 0 to 100, with
lower scores representing worst health functioning and QoL.
Physical Activity
Levels of physical activity were assessed using the Short
Questionnaire to Assess Health-Enhancing Physical Activi-
ty [32] sports section in which participants indicate the types
of physical activities they presently do (e.g., swimming), the
frequency per week (e.g., 3 days per week), and duration per
day (e.g., 50 min). Bicycling and walking frequency were
also included. For the purpose of this study, the intensity of
each activity was not included. To score the physical activity
measure, total minutes of activity is calculated for each
activity by multiplying frequency (days/week) and duration
(minutes/day). Total physical activity score for each partic-
ipant was calculated by making the sum of each activity
score.
Behavior Regulation Patterns
Using the all-or-nothing and limiting behavior scales from
The Behavioral Responses to Illness Questionnaire (BRIQ),
behavior regulation patterns were assessed [33]. The first
dimension assesses the “boom-and-bust pattern” usually
observed in CFS, and the second dimension assesses the lim-
itations in daily activities and the excessive rest that patients
take due to their fatigue problems. Higher scores (ranging from
1 to 5) represent a more frequent use of a boom-and-bust
pattern and more reduced daily activities, respectively. Portu-
guese and Dutch versions of the BRIQ have a very good
internal consistency for the all-or-nothing scale (α00.84 and
α00.88, respectively), but much lower, although still accept-
able alphas, for the limiting behavior scale (0.68 and 0.72,
respectively).
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Patients’ Illness Representations
Using the Brief Illness Perception Questionnaire (brief IPQ),
the patients’ illness representations were assessed [34]. The
brief IPQ consists of eight items, rated on a 10-point scale,
representing eight illness perceptions: illness consequences,
timeline (expected duration of illness), personal control, treat-
ment control, identity (disease label), illness coherence
(understanding), illness concern, and emotional response.
The brief IPQ dimensions are scored separately. Higher scores
on illness consequences, timeline, identity, illness concern,
and emotional response indicate a higher perceived impact
of CFS. Higher scores on personal control, treatment control,
and illness coherence, represent more positive illness repre-
sentations or, in other words, control over the illness.
Data Analyses
Descriptive data and differences between the Portuguese and
Dutch samples for demographics and clinical information
related to CFS were explored using univariate chi-square tests
(for dichotomous variables) and two-sided t tests (for contin-
uous variables). Pearson correlation coefficients were con-
ducted to examine the univariate relations between the
determinants and the dependent variables (fatigue severity,
and physical and psychological QoL). For statistical power
reasons, only determinants that showed a significant relation
with the dependent variables at a p<0.01 level in either sample
were entered in the subsequent hierarchical regression analy-
ses (Tables 2 and 3). Therefore, the regression analyses
examined the respective contribution of the behavioral charac-
teristics (physical activity, all-or-nothing behavior, and limiting
behavior) (block 1) and the illness representations consequen-
ces, personal control, identity, illness concern, and emotional
response (block 2) to fatigue severity (Table 4). In addition,
regression analyses were conducted to examine the association
between fatigue severity and somatic complaints on one hand
and physical and psychological QoL on the other hand. There
was no multicollinearity between the variables. For the regres-
sion analyses, we considered p values lower than or equal to
0.05 as significant. Data analyses were conducted using the
statistical software SPSS v19.
Results
Descriptive and Univariate Analyses
Table 1 presents descriptive data for both study populations
and the results of comparative tests for the following variables:
demographic characteristics, working status, use of health care
resources, fatigue symptoms, fatigue severity, somatic com-
plaints, psychological distress, and QoL (physical and
psychological functioning) in Portugal and The Netherlands.
A significant difference was found for educational level (p<0.
05). Dutch patients had a higher educational level than Portu-
guese patients. Furthermore, there was a significant difference
in working status: 68.7 % of the Dutch respondents reported
not to be working, while 44.7 % of the Portuguese reported not
to work. In addition, there was a longer duration of fatigue
symptoms (p<0.01) in the Dutch sample (13.8 years) than in
the Portuguese sample (10.7 years).
No significant differences were found for fatigue severity
and subjective experience of fatigue. Both Portuguese and
Dutch patients presented high levels of fatigue severity and
subjective experience of fatigue. The large majority of the
patients in both samples met clinical levels of fatigue. Portu-
guese patients reported a higher severity of (other) somatic
symptoms than Dutch patients (p<0.05). In relation to psycho-
logical distress, the Portuguese CFS patients reported signifi-
cantly higher levels of depression (p<0.001) and anxiety (p<
0.001), while significantly, more Portuguese participants also
reached a clinical level of depression (51.8 vs 10.2%; p<0.001)
and anxiety (64.7 vs 24 %; p<0.001). Both Portuguese and
Dutch patients presented low levels of physical and psycholog-
ical functioning, but the score for psychological functioning
was significantly higher in the Dutch population (p<0.01).
Hierarchical Regression Analyses
Table 4 shows the results of the hierarchical regressionmodels
for fatigue severity. In the Portuguese sample, the regression
model including the behavioral factors (block 1) was signifi-
cantly different from the null model (F(3)010.022, p<0.001)
and explained 27 % of the variance in fatigue severity. Higher
levels of physical activity were significantly associated with
lower fatigue severity (p<0.001). In addition, patients who
importantly reduced their daily activities (limiting behavior)
presented higher fatigue severity levels (p<0.05). Adding
illness representations to the model led to an increase of
18 % in explained variance (block 2). Higher identity beliefs
and higher emotional response were significantly associated
with higher fatigue severity levels (p<0.05 and p<0.01,
respectively). The final model explained 45 % of the variance
in fatigue severity (F(2)07.848, p<0.001). With respect to the
fatigue severity in the Dutch sample, the regression model
including the behavioral factors (block I) was also significant-
ly different from the null model (F(2)011.644, p<0.001)
and explained 18 % of the variance in fatigue severity.
Patients who adopted an all-or-nothing behavior pattern
presented higher fatigue severity levels (p<0.05). Illness
representations (block 2) led to a significant increase in
the explained variance (27 %). A higher belief in personal
control over CFS was significantly associated with lower
levels of fatigue severity (p<0.001). Furthermore, patients
who considered the illness as threatening (consequences)
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presented higher fatigue severity levels (p<0.01). The final
model explained 46 % of the variance in fatigue severity
(F(8)016.287, p<0.001).
The regression model for physical QoL including fatigue
severity and somatic complaints was significantly different
from the null model, in both the Portuguese (F(2)012.262,
p<0.001) and the Dutch (F(2)22.71, p<0.001) sample,
explaining 23 and 22 %, respectively, of the variance in this
variable. Higher fatigue severity and somatic distress were
significantly associated with lower levels of physical func-
tioning in Portuguese (ß0−0.39, p<0.001 and ß0−0.23, p<
0.05, respectively) and Dutch patients (ß0−0.17, p<0.05 and
ß0−0.19, p<0.05, respectively). Similar results were found
for psychological QoL. The regression models including fa-
tigue severity and somatic complaints were significantly dif-
ferent from the null model in both the Portuguese (F(2)0
25.207, p<0.001) and the Dutch sample (F(2)012.727, p<
0.001), explaining 46 and 14 %, respectively, of the variance
in psychological QoL. Higher fatigue severity was significant-
ly associated with lower levels of psychological functioning in
both samples (ß0−0.49, p<0.001 and ß0−0.29, p<0.001,
respectively). In the Portuguese sample, a higher level of
somatic distress was also significantly associated with lower
psychological QoL (ß0−0.34, p<0.001).
Discussion
In this cross-cultural study, we found a difference in educa-
tional level: the Dutch patients were more educated. This
difference is in line with available data on educational level
in these countries [35]. An important finding was the high rate
of patients not working at the time of study participation. Even
though we do not know why patients were not working, this
confirms the high levels of functional impairment in CFS
patients [2, 4]. Our results show that this is even much more
pronounced in Dutch patients. Apart from cultural differences
between both countries, this difference can also be attributed
to economical factors and differences in the health care and
social security system. Another possible explanation is the
significantly longer duration of chronic fatigue that was ob-
served in the Dutch patients.
As expected, levels of fatigue severity were very high and
the majority of the patients met a clinical level of CFS in both
countries. In addition, physical and psychological QoL were
poor in both samples, confirming earlier findings showing that
high levels of disability are associatedwith CFS [2, 3]. Fatigue
severity and somatic complaints were significantly associated
with lower physical QoL in both samples. In the Portuguese
sample, psychological functioning was significantly lower,
and depression and anxiety were significantly higher. About
half of the Portuguese patients even met clinical levels of
anxiety and depression. These results are in line with the
cultural differences in the experience and expression of dis-
tress between both countries [24]. These important differences
in psychological distress can also be explained by the fact that
CFS is, in contrast to The Netherlands, not recognized as a
specific disorder by primary care health professionals in Por-
tugal. As a result, Portuguese patients may present with higher
levels of frustration, anxiety, and feelings of loneliness, help-
lessness, and hopelessness [8].
The second study question regards the contribution of
behavioral and cognitive variables to fatigue severity in both
samples. The regression models explained 45 % (Portugal)
and 46 % (Netherlands) of the variance in fatigue severity.
Interestingly, there are important differences in the determi-
nants that were significantly associated with fatigue severity.
In relation to the behavioral determinants, higher levels of
physical activity were significantly associated with lower
levels of fatigue severity in the Portuguese sample, which is
in accordance with previous research [36, 37] and strengthens
the current recommendation for CFS patients to engage in
physical activity rather than refraining from it [38]. Addition-
ally, limiting behavior (reducing daily activities and excessive
resting) was also significantly associated with fatigue severity
in the Portuguese patients. The fact that Dutch patients were
more physically active and that physical activity was not a
significant determinant of fatigue severity in this sample backs
the importance of tailored physical activity for CFS patients
(e.g., Graded Exercise Therapy). However, finding a good
balance between activity and rest on a daily basis is equally
important [18, 33, 38]. This assumption is reinforced by the
fact that a boom-and-bust (all-or-none behavior) cycle was
Table 4 Hierarchical regression analyses for fatigue severity by
country
Fatigue severity
Portugal Netherlands
Predictors ΔR2 ß ΔR2 ß
Block 1 (behavioral factors) 0.27** 0.18**
Physical activity −31** 0.03
All-or-nothing behavior 0.13 0.16*
Limiting behavior 0.20* 0.12
Block 4 (Illness
representations)
0.18** 0.27**
Consequences −0.03 0.22**
Personal control −0.09 −0.34**
Identity 0.25* 0.08
Concern −0.16 0.03
Emotional response 0.38** 0.14
R2 0.45 0.46
Adj. R2 Model 0.40** 0.43**
Standardized beta coefficients (ß) represent the beta at final entry
*p<0.05;**p<0.01
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significantly associated with higher fatigue severity levels in
the Dutch patients, which is in line with previous research [13,
16]. With respect to illness representations, in the Portuguese
sample, the belief that CFS is a very serious condition
(identity) was significantly associated with higher fatigue
severity levels. This result confirms earlier findings that
patients who believe that their illness is very severe adopt
more passive ways of dealing with their health problem (such
as limiting behavior) and, as a result of that, present higher
levels of disability and psychological distress [2, 13, 17]. In
fact, emotional response was also significantly associatedwith
fatigue severity in the Portuguese sample. Emotional response
was a significant determinant only in the Portuguese sample,
which is in line with existing differences in psychological
distress between the two countries [24]. For Dutch patients,
the perception of having personal control over the illness was
significantly associated with lower fatigue levels. On the other
hand, thinking that CFS has severe consequences was signif-
icantly associated with higher fatigue severity. Overall, our
findings are in line with previous research in which positive
illness beliefs are associated with lower fatigue severity, and
negative beliefs with higher fatigue severity [13].
While these findings are valuable, several limitations of this
study should be discussed. A major limitation is that it was
carried out in health care centers and patients associations. As a
consequence, the results cannot be generalized to the whole
CFS population in both countries. In addition, there was a
difference in recruitment strategy. Portuguese patients were
partly recruited via medical doctors, while all Dutch patients
were recruited via e-mail by the patient association only. This
may have led to a selection bias. Moreover, due to the fact that
the confirmation of the diagnosis of CFS was based on self
reports, it cannot be excluded that some patients do not fulfill
all the CDC criteria for CFS. Ideally, this diagnosis should also
rule out other somatic and psychiatric causes of the symptoms,
by means of a full clinical assessment. Differences between the
two samples in depression, anxiety and psychological QoL,
can thus also be attributed to differences in diagnosis. Another
limitation is the cross-sectional design of the study which
limits the conclusions that can be drawn about the causality
of the relationships. A longitudinal study would provide more
valid data on the psychological predictors of CFS and the
relationship between fatigue severity and disability. Moreover,
there were differences in the sample size, and only female
patients were included in the analyses. Finally, due to the fact
that there are no normative data for the Portuguese CIS-20R
and the BSI, the comparisons of the respective clinical levels
should be interpreted with care.
Despite these limitations, this study is innovative due to
fact that cross-cultural research on psychological aspects of
CFS is very limited. CFS is considered to be a multifactorial
disorder, with biological, social, and psychological factors
contributing to its onset and perpetuation. Our findings
suggest that fatigue severity and related impairment are very
similar in CFS patients from Portugal and The Netherlands,
which is in line with the idea that the illness is not restricted to
one type of culture [22, 23]. Nevertheless, there seem to be
significant differences in psychological distress between the
Portuguese and the Dutch patients. This study shows that a
psychological approach can contribute to the understanding
and treatment of CFS. The fact that illness representations and
behavioral patterns were important determinants of fatigue
severity in both countries suggest that similar interventions,
such as psychological interventions that address patients’
beliefs about their illness as well as interventions that focus
on behavioral regulation or modification strategies, should be
offered internationally. However, due to the differences found
in the specific determinants, interventions should also be
tailored to patients’ needs and focus more on emotion regula-
tion and the increase of physical activity levels in Portuguese
patients, while encouraging personal control and establishing
a good balance between daily activities and rest can be im-
portant intervention targets for Dutch patients.
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